Hikma Pharmaceutical reported 652M in Cost of Sales for its second fiscal semester of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cost Of Sales Change
AstraZeneca AZN:LN 3068M 756M
Bayer BAYN:GR € 3685M 202M
Fresenius FRE:GR € 7254M 453M
GRIFOLS GRF:SM € 771.1M 119.7M
Hikma Pharmaceutical HIK:LN 652M 52M
Lonza Group LONN:SW 1.8B 301M
Orion ORNBV:FH 122.9M 12.6M
Recordati REC:IM 107.06M 5.19M